Stifel Nicolaus Keeps Their Buy Rating on Senseonics Holdings (SENS)
Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Earnings Call Summary | Senseonics(SENS.US) Q1 2024 Earnings Conference
The following is a summary of the Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript:Financial Performance:Senseonics' Q1 revenue totaled $5.1 million, marking a growth rate of 22% comp
Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript
Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript
Mercy to Use Senseonics Eversense RPM to Monitor Diabetic Patients
Senseonics Continues To Expect H1'2024 Global Net Revenue To Be $10M, Representing Growth Of 16% Y/Y
Senseonics Continues To Expect H1'2024 Global Net Revenue To Be $10M, Representing Growth Of 16% Y/Y
Senseonics: Q1 Earnings Snapshot
Senseonics | 10-Q: Quarterly report
Senseonics Holdings Q1 2024 GAAP EPS $(0.03), Inline, Sales $5.047M Beat $4.605M Estimate
Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. The company reported quarterly sales of $5.047 million which beat the analyst
Senseonics Holdings 1Q Loss $18.9M >SENS
Senseonics Holdings 1Q Loss $18.9M >SENS
Senseonics Holdings 1Q Loss/Shr 3c >SENS
Senseonics Holdings 1Q Loss/Shr 3c >SENS
Press Release: Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results GERMANTOWN, Md.--(BUSINESS WIRE)--May 13, 2024-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Enhancing patient care and advancing innovation with the only long-term implantable continuous glucose monitor Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and
Sensus Healthcare Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Sensus Healthcare Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Senseonics, Rimidi Team up on Diabetes Monitoring Solution
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos
Eversense CGM System Receives ICGM Designation by the US FDA
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company
Senseonics Board Shift: Schumm Out, Hansen In Until 2025
Even Though Sensirion Holding (VTX:SENS) Has Lost CHF67m Market Cap in Last 7 Days, Shareholders Are Still up 48% Over 5 Years
While Sensirion Holding AG (VTX:SENS) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 23% in the last quarter.
No Data